Diane C. Young - Jun 7, 2024 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role: SVP, CHIEF MEDICAL OFFICER
Signature: /s/ Sam Martin, attorney-in-fact for Diane C. Young
Stock symbol: CLDX
Transactions as of: Jun 7, 2024
Transactions value $: -$1,586,844
Form type: 4
Date filed: 6/11/2024, 04:01 PM
Previous filing: Jun 20, 2023
Next filing: Jun 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLDX	Common Stock	Sale	-$1.59M	-45K	-95.51%	$35.26	2.12K	Jun 7, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.67 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.67 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.